Provider Resources
Education
HCP Consensus Statements from
CJON
HCP Toolkits
ctDNA Testing for Response Monitoring
BRAF Testing
Care Step Pathways
Side Effect Search
Videos
Decision Support Tools
Options for Stage II Melanoma
Options for Stage III Melanoma
Options for Stage IV Melanoma
Patient Resources
Patient Action Plans
Non-Invasive Evaluation Tools For Suspicious Spots
BRAF Q&A
ctDNA Testing Handout
Videos
International Resources
Australia
Canada
France
Germany
Italy
Portugal
Spain
UK
Provider Resources
Education
HCP Consensus Statements from
CJON
HCP Toolkits
ctDNA Testing for Response Monitoring
BRAF Testing
Care Step Pathways
Side Effect Search
Videos
Decision Support Tools
Options for Stage II Melanoma
Options for Stage III Melanoma
Options for Stage IV Melanoma
Patient Resources
Patient Action Plans
Non-Invasive Evaluation Tools For Suspicious Spots
BRAF Q&A
ctDNA Testing Handout
Videos
International Resources
Australia
Canada
France
Germany
Italy
Portugal
Spain
UK
Profile
Topics Started
Replies Created
Engagements
Forum Replies Created
Viewing 1 post (of 1 total)
Author
Posts
February 19, 2018 at 7:24 am
in reply to:
hepatotoxicity
#4703
yael silman
Thank you.
I didnt mention that patient has no liver mets, neg for viral infections.
Author
Posts
Viewing 1 post (of 1 total)
Login
Log In
Username:
Password:
Keep me signed in
Log In
Register
Lost Password
Latest Activity
Immunotherapy in Hepatitis B carriers
topic by
Suzanne McGettigan
February 25
in
Other
Esophagitis
reply by
Suzanne McGettigan
February 18
in
Side-effect management
mucositis & mouth sores from Nivo
reply by
Kathleen Madden
January 27
in
Side-effect management
Immunotherapy and Solid organ transplant
reply by
Krista Rubin
January 23
in
Other
Nivolumab dilution
reply by
Kathleen Madden
November 18
in
Dosing and administration
© 2024 The Melanoma Hub, Terranova Medica, LLC, and Integrita Foundation, LLC. All rights reserved.
